

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.35213746 |
| 2 | actin-myosin filament sliding (GO:0033275) | 8.70113158 |
| 3 | muscle filament sliding (GO:0030049) | 8.70113158 |
| 4 | cardiac myofibril assembly (GO:0055003) | 7.95004028 |
| 5 | myofibril assembly (GO:0030239) | 7.73703441 |
| 6 | regulation of skeletal muscle contraction (GO:0014819) | 7.57035987 |
| 7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.51143243 |
| 8 | actin-mediated cell contraction (GO:0070252) | 7.20479221 |
| 9 | plasma membrane repair (GO:0001778) | 7.00918255 |
| 10 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.76579502 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.40489072 |
| 12 | cardiac muscle contraction (GO:0060048) | 6.35927370 |
| 13 | cardiac muscle cell development (GO:0055013) | 6.10140191 |
| 14 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.06289336 |
| 15 | actomyosin structure organization (GO:0031032) | 6.02400142 |
| 16 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.85292544 |
| 17 | striated muscle contraction (GO:0006941) | 5.80585077 |
| 18 | cardiac cell development (GO:0055006) | 5.72884253 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 5.70191289 |
| 20 | tricarboxylic acid cycle (GO:0006099) | 5.69599925 |
| 21 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.51084944 |
| 22 | actin filament-based movement (GO:0030048) | 5.46417824 |
| 23 | carnitine shuttle (GO:0006853) | 5.42733701 |
| 24 | regulation of relaxation of muscle (GO:1901077) | 5.40214485 |
| 25 | skeletal muscle contraction (GO:0003009) | 5.32098405 |
| 26 | adult heart development (GO:0007512) | 5.30474552 |
| 27 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.20673773 |
| 28 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.16074079 |
| 29 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.13223040 |
| 30 | skeletal muscle fiber development (GO:0048741) | 5.11359539 |
| 31 | * positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.09378543 |
| 32 | regulation of cell communication by electrical coupling (GO:0010649) | 5.06314778 |
| 33 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.06209858 |
| 34 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.00258146 |
| 35 | cardiac muscle hypertrophy (GO:0003300) | 4.88796421 |
| 36 | regulation of striated muscle contraction (GO:0006942) | 4.88541649 |
| 37 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.85494216 |
| 38 | myotube cell development (GO:0014904) | 4.83501265 |
| 39 | regulation of sarcomere organization (GO:0060297) | 4.81478613 |
| 40 | muscle tissue morphogenesis (GO:0060415) | 4.81104195 |
| 41 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.79774665 |
| 42 | heart trabecula formation (GO:0060347) | 4.77852411 |
| 43 | striated muscle hypertrophy (GO:0014897) | 4.71921683 |
| 44 | * regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.69893900 |
| 45 | fatty acid transmembrane transport (GO:1902001) | 4.61895048 |
| 46 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.59247842 |
| 47 | heart contraction (GO:0060047) | 4.44904023 |
| 48 | heart process (GO:0003015) | 4.44904023 |
| 49 | regulation of membrane repolarization (GO:0060306) | 4.43621872 |
| 50 | creatine metabolic process (GO:0006600) | 4.38211383 |
| 51 | skeletal muscle adaptation (GO:0043501) | 4.33256909 |
| 52 | skeletal muscle tissue development (GO:0007519) | 4.25130026 |
| 53 | muscle contraction (GO:0006936) | 4.24097205 |
| 54 | response to inactivity (GO:0014854) | 4.21617205 |
| 55 | regulation of cofactor metabolic process (GO:0051193) | 4.18494829 |
| 56 | regulation of coenzyme metabolic process (GO:0051196) | 4.18494829 |
| 57 | muscle cell fate commitment (GO:0042693) | 4.16950884 |
| 58 | muscle hypertrophy (GO:0014896) | 4.15677766 |
| 59 | regulation of the force of heart contraction (GO:0002026) | 4.09236519 |
| 60 | muscle cell cellular homeostasis (GO:0046716) | 4.03629514 |
| 61 | carnitine transmembrane transport (GO:1902603) | 3.99939139 |
| 62 | striated muscle cell development (GO:0055002) | 3.99616518 |
| 63 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.98491429 |
| 64 | cell communication involved in cardiac conduction (GO:0086065) | 3.98175445 |
| 65 | muscle system process (GO:0003012) | 3.92525462 |
| 66 | striated muscle adaptation (GO:0014888) | 3.92466384 |
| 67 | muscle organ development (GO:0007517) | 3.79715666 |
| 68 | glucan biosynthetic process (GO:0009250) | 3.77117201 |
| 69 | glycogen biosynthetic process (GO:0005978) | 3.77117201 |
| 70 | muscle structure development (GO:0061061) | 3.77058284 |
| 71 | cardiac muscle adaptation (GO:0014887) | 3.73623805 |
| 72 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.73623805 |
| 73 | muscle hypertrophy in response to stress (GO:0003299) | 3.73623805 |
| 74 | negative regulation of potassium ion transport (GO:0043267) | 3.71645243 |
| 75 | regulation of cardiac muscle contraction (GO:0055117) | 3.69779511 |
| 76 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.68370096 |
| 77 | striated muscle atrophy (GO:0014891) | 3.67797143 |
| 78 | negative regulation of protein localization to cell surface (GO:2000009) | 3.64988361 |
| 79 | cardiac muscle cell action potential (GO:0086001) | 3.64937550 |
| 80 | carnitine transport (GO:0015879) | 3.63519526 |
| 81 | amino-acid betaine transport (GO:0015838) | 3.63519526 |
| 82 | regulation of ATP catabolic process (GO:1903289) | 3.61857255 |
| 83 | regulation of ATPase activity (GO:0043462) | 3.61857255 |
| 84 | regulation of heart rate (GO:0002027) | 3.61610055 |
| 85 | NADH metabolic process (GO:0006734) | 3.61139555 |
| 86 | 2-oxoglutarate metabolic process (GO:0006103) | 3.58227240 |
| 87 | regulation of myoblast differentiation (GO:0045661) | 3.57592021 |
| 88 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.56252840 |
| 89 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.54107200 |
| 90 | muscle fiber development (GO:0048747) | 3.54062662 |
| 91 | response to muscle activity (GO:0014850) | 3.51569140 |
| 92 | glycogen catabolic process (GO:0005980) | 3.50910677 |
| 93 | skeletal muscle tissue regeneration (GO:0043403) | 3.49438914 |
| 94 | positive regulation of myoblast differentiation (GO:0045663) | 3.47312209 |
| 95 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.45278363 |
| 96 | muscle cell development (GO:0055001) | 3.44700248 |
| 97 | regulation of muscle contraction (GO:0006937) | 3.44348182 |
| 98 | cellular polysaccharide catabolic process (GO:0044247) | 3.43971813 |
| 99 | cell communication by electrical coupling (GO:0010644) | 3.43478962 |
| 100 | regulation of cardioblast differentiation (GO:0051890) | 3.41236323 |
| 101 | regulation of sulfur metabolic process (GO:0042762) | 3.39695055 |
| 102 | regulation of heart contraction (GO:0008016) | 3.39284300 |
| 103 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.37596373 |
| 104 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.35671089 |
| 105 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.33726201 |
| 106 | striated muscle tissue development (GO:0014706) | 3.32767731 |
| 107 | regulation of sequestering of triglyceride (GO:0010889) | 3.31262155 |
| 108 | muscle adaptation (GO:0043500) | 3.30169442 |
| 109 | myoblast fusion (GO:0007520) | 3.27448563 |
| 110 | glucan catabolic process (GO:0009251) | 3.26744807 |
| 111 | positive regulation of myotube differentiation (GO:0010831) | 3.25966579 |
| 112 | relaxation of muscle (GO:0090075) | 3.25404067 |
| 113 | * regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.24712085 |
| 114 | * regulation of calcium ion transmembrane transport (GO:1903169) | 3.24712085 |
| 115 | relaxation of cardiac muscle (GO:0055119) | 3.22759777 |
| 116 | muscle atrophy (GO:0014889) | 3.21761439 |
| 117 | positive regulation of heart contraction (GO:0045823) | 3.21475386 |
| 118 | regulation of muscle system process (GO:0090257) | 3.17467666 |
| 119 | cardiac chamber formation (GO:0003207) | 3.16978530 |
| 120 | trabecula formation (GO:0060343) | 3.14979649 |
| 121 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.13208313 |
| 122 | cardiac conduction (GO:0061337) | 3.12330062 |
| 123 | regulation of myotube differentiation (GO:0010830) | 3.10080831 |
| 124 | polysaccharide catabolic process (GO:0000272) | 3.07111323 |
| 125 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.03411309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.84830921 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.25843749 |
| 3 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.78239162 |
| 4 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.78239162 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.58388599 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.56228162 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.33274476 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.25266117 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.25237004 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.10495757 |
| 11 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.95525188 |
| 12 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.71355490 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.17107272 |
| 14 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.16521584 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.16073029 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.14678036 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.05847936 |
| 18 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.01543692 |
| 19 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.00572677 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.00352957 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.98056673 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.85475668 |
| 23 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.73288516 |
| 24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.70813104 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.69399007 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68247582 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.62962089 |
| 28 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.57199101 |
| 29 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.57088581 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.56915837 |
| 31 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.54958712 |
| 32 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.51889407 |
| 33 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.45250072 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44368816 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42906514 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40769836 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40048438 |
| 38 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38200363 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36793358 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.33086778 |
| 41 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.32931782 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32449539 |
| 43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30785799 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.26106030 |
| 45 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24541469 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23700828 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23574439 |
| 48 | ATF3_27146783_Chip-Seq_COLON_Human | 1.23255916 |
| 49 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.20673151 |
| 50 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.20673151 |
| 51 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.19980140 |
| 52 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19495966 |
| 53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19495966 |
| 54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18278550 |
| 55 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.17882065 |
| 56 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.17333328 |
| 57 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16239924 |
| 58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.15465488 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14503015 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13993592 |
| 61 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.12415164 |
| 62 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.12211272 |
| 63 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12178559 |
| 64 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11951742 |
| 65 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10627323 |
| 66 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.09440611 |
| 67 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09380876 |
| 68 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.08901032 |
| 69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.08824092 |
| 70 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.06923132 |
| 71 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06804665 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05481569 |
| 73 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04996183 |
| 74 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04477694 |
| 75 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.04036610 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02690443 |
| 77 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00686698 |
| 78 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00113604 |
| 79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99843304 |
| 80 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98949239 |
| 81 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.98399997 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97960370 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97351400 |
| 84 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.96984561 |
| 85 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.96634265 |
| 86 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96246895 |
| 87 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94889967 |
| 88 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.94760383 |
| 89 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94002053 |
| 90 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93743883 |
| 91 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.92316800 |
| 92 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92148906 |
| 93 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91935958 |
| 94 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.91803668 |
| 95 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.91232902 |
| 96 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91184094 |
| 97 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90506382 |
| 98 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89775369 |
| 99 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89685546 |
| 100 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.88410742 |
| 101 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87805729 |
| 102 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.87766648 |
| 103 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87510045 |
| 104 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.87317516 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87267527 |
| 106 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.86874295 |
| 107 | * P68_20966046_ChIP-Seq_HELA_Human | 0.86835555 |
| 108 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85259913 |
| 109 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.84559391 |
| 110 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.84414591 |
| 111 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.84082260 |
| 112 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.84073683 |
| 113 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.83748933 |
| 114 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.83466238 |
| 115 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.83412894 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82432245 |
| 117 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81477513 |
| 118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.81285260 |
| 119 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81215662 |
| 120 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.80920293 |
| 121 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.80861510 |
| 122 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80228659 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80188230 |
| 124 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.80061126 |
| 125 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79759576 |
| 126 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.79444949 |
| 127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79270632 |
| 128 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.78971999 |
| 129 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.78582337 |
| 130 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.78275652 |
| 131 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.78240236 |
| 132 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.78107855 |
| 133 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77979046 |
| 134 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.77543610 |
| 135 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77175494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.53794648 |
| 2 | MP0003646_muscle_fatigue | 5.67325899 |
| 3 | MP0000751_myopathy | 5.57530952 |
| 4 | MP0004084_abnormal_cardiac_muscle | 5.10670429 |
| 5 | MP0000749_muscle_degeneration | 4.56981015 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.39253512 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.09952100 |
| 8 | MP0005330_cardiomyopathy | 3.60764531 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.54626814 |
| 10 | * MP0004087_abnormal_muscle_fiber | 3.24832881 |
| 11 | MP0000750_abnormal_muscle_regeneration | 3.20021833 |
| 12 | MP0002106_abnormal_muscle_physiology | 3.02537301 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.91732310 |
| 14 | MP0002972_abnormal_cardiac_muscle | 2.82789527 |
| 15 | MP0002269_muscular_atrophy | 2.66494604 |
| 16 | MP0000747_muscle_weakness | 2.64328988 |
| 17 | MP0004130_abnormal_muscle_cell | 2.60000126 |
| 18 | MP0003137_abnormal_impulse_conducting | 2.52334628 |
| 19 | MP0000759_abnormal_skeletal_muscle | 2.50734343 |
| 20 | MP0005369_muscle_phenotype | 2.48379681 |
| 21 | MP0008775_abnormal_heart_ventricle | 2.47986362 |
| 22 | * MP0010630_abnormal_cardiac_muscle | 2.33294228 |
| 23 | * MP0005385_cardiovascular_system_phenoty | 2.21972975 |
| 24 | * MP0001544_abnormal_cardiovascular_syste | 2.21972975 |
| 25 | MP0004484_altered_response_of | 2.13683772 |
| 26 | MP0006138_congestive_heart_failure | 2.11407961 |
| 27 | MP0004233_abnormal_muscle_weight | 1.98444732 |
| 28 | MP0003828_pulmonary_edema | 1.88522912 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.71287454 |
| 30 | * MP0004085_abnormal_heartbeat | 1.64682229 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.52936759 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.52858141 |
| 33 | MP0004510_myositis | 1.52339943 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.50723552 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.46868516 |
| 36 | MP0002127_abnormal_cardiovascular_syste | 1.39433310 |
| 37 | MP0000733_abnormal_muscle_development | 1.31428399 |
| 38 | MP0003279_aneurysm | 1.26431579 |
| 39 | MP0002108_abnormal_muscle_morphology | 1.25829553 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.20004395 |
| 41 | MP0001661_extended_life_span | 1.19542346 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.18111494 |
| 43 | MP0002234_abnormal_pharynx_morphology | 1.15421331 |
| 44 | MP0008438_abnormal_cutaneous_collagen | 1.13962711 |
| 45 | MP0005670_abnormal_white_adipose | 1.13457524 |
| 46 | MP0003567_abnormal_fetal_cardiomyocyte | 1.10915067 |
| 47 | MP0005375_adipose_tissue_phenotype | 1.07208068 |
| 48 | MP0000343_altered_response_to | 1.06539345 |
| 49 | * MP0000266_abnormal_heart_morphology | 1.05511529 |
| 50 | MP0004270_analgesia | 1.03639148 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.03248909 |
| 52 | MP0005623_abnormal_meninges_morphology | 0.98390824 |
| 53 | MP0003566_abnormal_cell_adhesion | 0.92928138 |
| 54 | MP0005275_abnormal_skin_tensile | 0.90393971 |
| 55 | MP0005165_increased_susceptibility_to | 0.85988346 |
| 56 | MP0006035_abnormal_mitochondrial_morpho | 0.84448437 |
| 57 | MP0000013_abnormal_adipose_tissue | 0.83236084 |
| 58 | MP0002128_abnormal_blood_circulation | 0.78731243 |
| 59 | MP0005266_abnormal_metabolism | 0.78500845 |
| 60 | MP0010030_abnormal_orbit_morphology | 0.75931216 |
| 61 | MP0002971_abnormal_brown_adipose | 0.72975653 |
| 62 | MP0000230_abnormal_systemic_arterial | 0.71893765 |
| 63 | MP0000767_abnormal_smooth_muscle | 0.70465501 |
| 64 | MP0000003_abnormal_adipose_tissue | 0.69099006 |
| 65 | MP0004272_abnormal_basement_membrane | 0.65742199 |
| 66 | MP0003941_abnormal_skin_development | 0.63211777 |
| 67 | MP0001879_abnormal_lymphatic_vessel | 0.62081203 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 0.57025352 |
| 69 | MP0004134_abnormal_chest_morphology | 0.54043566 |
| 70 | MP0002925_abnormal_cardiovascular_devel | 0.48011933 |
| 71 | MP0005451_abnormal_body_composition | 0.47992308 |
| 72 | MP0001958_emphysema | 0.47015031 |
| 73 | MP0008961_abnormal_basal_metabolism | 0.46297159 |
| 74 | MP0009250_abnormal_appendicular_skeleto | 0.45734926 |
| 75 | MP0002909_abnormal_adrenal_gland | 0.45337193 |
| 76 | MP0004147_increased_porphyrin_level | 0.44135401 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 0.43741121 |
| 78 | MP0005503_abnormal_tendon_morphology | 0.43248567 |
| 79 | MP0004043_abnormal_pH_regulation | 0.43204330 |
| 80 | MP0009384_cardiac_valve_regurgitation | 0.43096338 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.42953532 |
| 82 | MP0003879_abnormal_hair_cell | 0.41882509 |
| 83 | MP0005187_abnormal_penis_morphology | 0.41221514 |
| 84 | MP0001614_abnormal_blood_vessel | 0.39947075 |
| 85 | MP0003045_fibrosis | 0.37947506 |
| 86 | MP0002114_abnormal_axial_skeleton | 0.37656529 |
| 87 | MP0004858_abnormal_nervous_system | 0.36006783 |
| 88 | MP0001784_abnormal_fluid_regulation | 0.34582675 |
| 89 | MP0000462_abnormal_digestive_system | 0.34494694 |
| 90 | MP0003948_abnormal_gas_homeostasis | 0.34223473 |
| 91 | MP0002249_abnormal_larynx_morphology | 0.32995329 |
| 92 | MP0000534_abnormal_ureter_morphology | 0.32965680 |
| 93 | MP0001299_abnormal_eye_distance/ | 0.31631181 |
| 94 | MP0005334_abnormal_fat_pad | 0.31296278 |
| 95 | MP0009780_abnormal_chondrocyte_physiolo | 0.30454037 |
| 96 | MP0003984_embryonic_growth_retardation | 0.28158615 |
| 97 | MP0002822_catalepsy | 0.27511176 |
| 98 | MP0002088_abnormal_embryonic_growth/wei | 0.27256005 |
| 99 | MP0000579_abnormal_nail_morphology | 0.26117440 |
| 100 | MP0005595_abnormal_vascular_smooth | 0.25561250 |
| 101 | MP0009115_abnormal_fat_cell | 0.24768284 |
| 102 | MP0002896_abnormal_bone_mineralization | 0.24474836 |
| 103 | MP0002168_other_aberrant_phenotype | 0.24248444 |
| 104 | MP0002877_abnormal_melanocyte_morpholog | 0.23979572 |
| 105 | MP0005409_darkened_coat_color | 0.23744896 |
| 106 | MP0005376_homeostasis/metabolism_phenot | 0.22848048 |
| 107 | MP0000249_abnormal_blood_vessel | 0.22096956 |
| 108 | MP0001727_abnormal_embryo_implantation | 0.21813108 |
| 109 | MP0008569_lethality_at_weaning | 0.21154702 |
| 110 | MP0005083_abnormal_biliary_tract | 0.20870295 |
| 111 | MP0002295_abnormal_pulmonary_circulatio | 0.20750649 |
| 112 | MP0003091_abnormal_cell_migration | 0.20728144 |
| 113 | MP0005535_abnormal_body_temperature | 0.19955618 |
| 114 | MP0005023_abnormal_wound_healing | 0.19821315 |
| 115 | MP0001943_abnormal_respiration | 0.19654073 |
| 116 | MP0005452_abnormal_adipose_tissue | 0.19224213 |
| 117 | MP0003385_abnormal_body_wall | 0.17731590 |
| 118 | MP0002970_abnormal_white_adipose | 0.17040709 |
| 119 | MP0002118_abnormal_lipid_homeostasis | 0.16444721 |
| 120 | MP0000762_abnormal_tongue_morphology | 0.16205473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.28064063 |
| 2 | Exercise-induced myalgia (HP:0003738) | 6.86636602 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 6.69747032 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.65360401 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.48514131 |
| 6 | Muscle fiber splitting (HP:0003555) | 6.28525616 |
| 7 | Abnormality of the calf musculature (HP:0001430) | 5.50887450 |
| 8 | Hyporeflexia of lower limbs (HP:0002600) | 5.45129862 |
| 9 | Subaortic stenosis (HP:0001682) | 5.23894888 |
| 10 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.23894888 |
| 11 | * Ventricular tachycardia (HP:0004756) | 5.14643365 |
| 12 | Myoglobinuria (HP:0002913) | 4.97949429 |
| 13 | Atrial fibrillation (HP:0005110) | 4.86851444 |
| 14 | Muscle fiber inclusion bodies (HP:0100299) | 4.85988263 |
| 15 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.85222328 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.75548850 |
| 17 | Increased connective tissue (HP:0009025) | 4.70946069 |
| 18 | Type 1 muscle fiber predominance (HP:0003803) | 4.69584934 |
| 19 | Lipoatrophy (HP:0100578) | 4.63319641 |
| 20 | Difficulty running (HP:0009046) | 4.60026176 |
| 21 | Primary atrial arrhythmia (HP:0001692) | 4.55152679 |
| 22 | Right ventricular cardiomyopathy (HP:0011663) | 4.42759727 |
| 23 | Supraventricular tachycardia (HP:0004755) | 4.39176192 |
| 24 | Supraventricular arrhythmia (HP:0005115) | 4.32076426 |
| 25 | Nemaline bodies (HP:0003798) | 4.06992176 |
| 26 | Asymmetric septal hypertrophy (HP:0001670) | 4.04804303 |
| 27 | Myotonia (HP:0002486) | 4.00756955 |
| 28 | Rhabdomyolysis (HP:0003201) | 3.91885871 |
| 29 | Dilated cardiomyopathy (HP:0001644) | 3.87591634 |
| 30 | Syncope (HP:0001279) | 3.80254173 |
| 31 | Bundle branch block (HP:0011710) | 3.78683543 |
| 32 | Difficulty climbing stairs (HP:0003551) | 3.73815244 |
| 33 | Prolonged QT interval (HP:0001657) | 3.63659650 |
| 34 | Ventricular arrhythmia (HP:0004308) | 3.46208318 |
| 35 | Round ear (HP:0100830) | 3.26970668 |
| 36 | Increased variability in muscle fiber diameter (HP:0003557) | 3.26143136 |
| 37 | Distal arthrogryposis (HP:0005684) | 3.24926586 |
| 38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.24269452 |
| 39 | Heart block (HP:0012722) | 3.23346745 |
| 40 | Muscle stiffness (HP:0003552) | 3.18986789 |
| 41 | Atrioventricular block (HP:0001678) | 3.16189631 |
| 42 | Abnormal atrioventricular conduction (HP:0005150) | 3.10641160 |
| 43 | Ventricular fibrillation (HP:0001663) | 3.05882436 |
| 44 | Myopathic facies (HP:0002058) | 3.02401277 |
| 45 | Neck muscle weakness (HP:0000467) | 2.98928096 |
| 46 | * Palpitations (HP:0001962) | 2.88256700 |
| 47 | Abnormal finger flexion creases (HP:0006143) | 2.76458921 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.71785700 |
| 49 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.71546690 |
| 50 | Areflexia of lower limbs (HP:0002522) | 2.69036302 |
| 51 | Limb-girdle muscle atrophy (HP:0003797) | 2.65887939 |
| 52 | Ulnar deviation of the wrist (HP:0003049) | 2.62060132 |
| 53 | Fetal akinesia sequence (HP:0001989) | 2.61633875 |
| 54 | Abnormal EKG (HP:0003115) | 2.60573908 |
| 55 | Abnormality of the calcaneus (HP:0008364) | 2.49025664 |
| 56 | Distal lower limb amyotrophy (HP:0008944) | 2.45519400 |
| 57 | Facial diplegia (HP:0001349) | 2.44555083 |
| 58 | Popliteal pterygium (HP:0009756) | 2.40607330 |
| 59 | Slender build (HP:0001533) | 2.39451890 |
| 60 | Scapular winging (HP:0003691) | 2.38470895 |
| 61 | Gowers sign (HP:0003391) | 2.37645054 |
| 62 | Rimmed vacuoles (HP:0003805) | 2.36785317 |
| 63 | Testicular atrophy (HP:0000029) | 2.36600727 |
| 64 | EMG: neuropathic changes (HP:0003445) | 2.35398181 |
| 65 | Hypoplastic ischia (HP:0003175) | 2.35144408 |
| 66 | Generalized muscle weakness (HP:0003324) | 2.29716459 |
| 67 | Muscular dystrophy (HP:0003560) | 2.25184433 |
| 68 | Palmoplantar keratoderma (HP:0000982) | 2.19469695 |
| 69 | Calcaneovalgus deformity (HP:0001848) | 2.12140862 |
| 70 | * Left ventricular hypertrophy (HP:0001712) | 2.11008104 |
| 71 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.10051905 |
| 72 | Waddling gait (HP:0002515) | 2.09885364 |
| 73 | Frequent falls (HP:0002359) | 2.08922503 |
| 74 | Ketoacidosis (HP:0001993) | 2.08410924 |
| 75 | Malignant hyperthermia (HP:0002047) | 2.06561334 |
| 76 | Abnormality of the ischium (HP:0003174) | 2.03787487 |
| 77 | Abnormality of the foot musculature (HP:0001436) | 2.03250312 |
| 78 | Abnormality of the neuromuscular junction (HP:0003398) | 2.02928846 |
| 79 | Fatigable weakness (HP:0003473) | 2.02928846 |
| 80 | Hepatic necrosis (HP:0002605) | 2.01034001 |
| 81 | Spinal rigidity (HP:0003306) | 2.00999839 |
| 82 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.98474084 |
| 83 | Absent phalangeal crease (HP:0006109) | 1.97958776 |
| 84 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.97160757 |
| 85 | Limb-girdle muscle weakness (HP:0003325) | 1.96006201 |
| 86 | Limited hip movement (HP:0008800) | 1.93869859 |
| 87 | Aortic aneurysm (HP:0004942) | 1.92734576 |
| 88 | Proximal amyotrophy (HP:0007126) | 1.91945045 |
| 89 | Foot dorsiflexor weakness (HP:0009027) | 1.91630291 |
| 90 | Acute necrotizing encephalopathy (HP:0006965) | 1.90793997 |
| 91 | Deformed tarsal bones (HP:0008119) | 1.90086878 |
| 92 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.88671141 |
| 93 | Lower limb amyotrophy (HP:0007210) | 1.87889682 |
| 94 | Broad metatarsal (HP:0001783) | 1.87764934 |
| 95 | Hip contracture (HP:0003273) | 1.86666474 |
| 96 | Conjunctival hamartoma (HP:0100780) | 1.85805924 |
| 97 | Bulbar palsy (HP:0001283) | 1.84713721 |
| 98 | Hyperkalemia (HP:0002153) | 1.83085644 |
| 99 | Ragged-red muscle fibers (HP:0003200) | 1.81844449 |
| 100 | Metatarsus adductus (HP:0001840) | 1.81424158 |
| 101 | Increased muscle lipid content (HP:0009058) | 1.81158351 |
| 102 | Congestive heart failure (HP:0001635) | 1.80428811 |
| 103 | Sudden cardiac death (HP:0001645) | 1.80297140 |
| 104 | Weak cry (HP:0001612) | 1.78281487 |
| 105 | Hypoglycemic coma (HP:0001325) | 1.74669016 |
| 106 | Aplasia of the musculature (HP:0100854) | 1.73832024 |
| 107 | Progressive muscle weakness (HP:0003323) | 1.72834504 |
| 108 | Hepatocellular necrosis (HP:0001404) | 1.72500523 |
| 109 | Type 2 muscle fiber atrophy (HP:0003554) | 1.72012748 |
| 110 | Exercise intolerance (HP:0003546) | 1.71223031 |
| 111 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.69642634 |
| 112 | Large for gestational age (HP:0001520) | 1.68130678 |
| 113 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.68120372 |
| 114 | Muscle fiber atrophy (HP:0100295) | 1.58750670 |
| 115 | Steppage gait (HP:0003376) | 1.56389718 |
| 116 | Amniotic constriction ring (HP:0009775) | 1.52637605 |
| 117 | Abnormality of placental membranes (HP:0011409) | 1.52637605 |
| 118 | Long clavicles (HP:0000890) | 1.51996819 |
| 119 | Nonprogressive disorder (HP:0003680) | 1.48993695 |
| 120 | Generalized amyotrophy (HP:0003700) | 1.46307923 |
| 121 | Ulnar deviation of finger (HP:0009465) | 1.45480235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.76051479 |
| 2 | OBSCN | 4.79153491 |
| 3 | PHKG2 | 4.51885276 |
| 4 | PHKG1 | 4.51885276 |
| 5 | MYLK | 3.42408438 |
| 6 | DMPK | 3.22521164 |
| 7 | TRIB3 | 3.11536755 |
| 8 | LMTK2 | 3.03391582 |
| 9 | PDK4 | 2.95220463 |
| 10 | PDK3 | 2.95220463 |
| 11 | PKN2 | 2.82805557 |
| 12 | MUSK | 2.31686819 |
| 13 | PIK3CA | 2.28740617 |
| 14 | NEK1 | 2.19530420 |
| 15 | BCKDK | 2.08504842 |
| 16 | PDK2 | 1.82935748 |
| 17 | PINK1 | 1.78984305 |
| 18 | TIE1 | 1.69282783 |
| 19 | STK24 | 1.55431310 |
| 20 | LIMK1 | 1.49255382 |
| 21 | PIK3CG | 1.47703821 |
| 22 | MAP2K3 | 1.40919424 |
| 23 | MAP3K7 | 1.34608041 |
| 24 | ILK | 1.25763865 |
| 25 | NME1 | 1.24922603 |
| 26 | MAPK12 | 1.22582394 |
| 27 | PAK3 | 1.17831786 |
| 28 | MAPKAPK3 | 1.12987519 |
| 29 | PRKD1 | 1.10320465 |
| 30 | RIPK1 | 1.09272716 |
| 31 | CAMK2D | 1.00963803 |
| 32 | ROCK1 | 0.98820714 |
| 33 | MARK1 | 0.98125336 |
| 34 | TRPM7 | 0.95589706 |
| 35 | PRKAA1 | 0.86182955 |
| 36 | PRKAA2 | 0.85046661 |
| 37 | PDGFRA | 0.84261820 |
| 38 | CDC42BPA | 0.83576471 |
| 39 | GRK7 | 0.82940832 |
| 40 | MAP3K5 | 0.79634268 |
| 41 | EPHB1 | 0.76101190 |
| 42 | MAP3K3 | 0.74728387 |
| 43 | CCNB1 | 0.69603232 |
| 44 | ZAK | 0.69453952 |
| 45 | FLT3 | 0.65956181 |
| 46 | DAPK3 | 0.65638332 |
| 47 | STK38L | 0.63035968 |
| 48 | TGFBR2 | 0.62497928 |
| 49 | ROCK2 | 0.61834086 |
| 50 | SIK1 | 0.61594052 |
| 51 | MAPK4 | 0.59758467 |
| 52 | STK4 | 0.59244539 |
| 53 | PKN1 | 0.59006176 |
| 54 | PTK2B | 0.56920097 |
| 55 | PTK6 | 0.56745365 |
| 56 | WNK4 | 0.56460067 |
| 57 | DDR2 | 0.54830319 |
| 58 | INSRR | 0.54645268 |
| 59 | CAMK2B | 0.54504943 |
| 60 | DYRK1B | 0.53926688 |
| 61 | MAP3K6 | 0.52389342 |
| 62 | ICK | 0.50037306 |
| 63 | NEK9 | 0.49879232 |
| 64 | STK38 | 0.49364218 |
| 65 | CAMK4 | 0.47062860 |
| 66 | PRKACB | 0.46783472 |
| 67 | RPS6KC1 | 0.46393357 |
| 68 | RPS6KL1 | 0.46393357 |
| 69 | LATS1 | 0.45460006 |
| 70 | KDR | 0.43205423 |
| 71 | CAMK2G | 0.42101670 |
| 72 | AKT2 | 0.41496408 |
| 73 | TESK1 | 0.40434688 |
| 74 | CAMK2A | 0.40430752 |
| 75 | MAP3K10 | 0.40099482 |
| 76 | KSR2 | 0.39446478 |
| 77 | MAP3K13 | 0.39318580 |
| 78 | WNK1 | 0.39286113 |
| 79 | LATS2 | 0.39021500 |
| 80 | RPS6KA6 | 0.38551664 |
| 81 | SGK3 | 0.37710722 |
| 82 | EPHB2 | 0.36819832 |
| 83 | MARK2 | 0.36012986 |
| 84 | PTK2 | 0.35885843 |
| 85 | PDPK1 | 0.34988804 |
| 86 | MAP2K4 | 0.34566693 |
| 87 | MTOR | 0.33772065 |
| 88 | ERBB3 | 0.33464283 |
| 89 | CAMK1 | 0.33449274 |
| 90 | PRKACA | 0.30929531 |
| 91 | EPHA3 | 0.30763507 |
| 92 | MAP2K6 | 0.30726786 |
| 93 | FER | 0.29999757 |
| 94 | TAOK1 | 0.29150060 |
| 95 | EEF2K | 0.29141453 |
| 96 | LRRK2 | 0.28909087 |
| 97 | RPS6KB2 | 0.28860540 |
| 98 | PAK2 | 0.28708186 |
| 99 | PRKACG | 0.28393017 |
| 100 | PDK1 | 0.24493576 |
| 101 | PRKCH | 0.24024146 |
| 102 | PRKCE | 0.23722007 |
| 103 | MET | 0.23519504 |
| 104 | RPS6KA1 | 0.21999112 |
| 105 | MAPK11 | 0.21605456 |
| 106 | RET | 0.20853392 |
| 107 | RPS6KA2 | 0.20697666 |
| 108 | MAPK10 | 0.20270006 |
| 109 | PRKG1 | 0.19455002 |
| 110 | PRKD3 | 0.18946947 |
| 111 | ERN1 | 0.18446310 |
| 112 | MAP2K1 | 0.18116219 |
| 113 | PRKG2 | 0.17632542 |
| 114 | RPS6KA3 | 0.17349953 |
| 115 | MOS | 0.17323121 |
| 116 | SGK2 | 0.16651043 |
| 117 | MAP3K11 | 0.16303785 |
| 118 | MAPK7 | 0.16259815 |
| 119 | PRPF4B | 0.15499463 |
| 120 | PAK6 | 0.15312177 |
| 121 | MAP3K1 | 0.14898844 |
| 122 | RAF1 | 0.11721217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.52790791 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.27958583 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.23241234 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.19715401 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.12989775 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.09035222 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.05470746 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.87143704 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.57534723 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51498675 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.40094500 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.32256025 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 1.96744701 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.95358940 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.92432011 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.90025565 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87438384 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.84374995 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.60451788 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.48134754 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34870672 |
| 22 | Insulin resistance_Homo sapiens_hsa04931 | 1.33218898 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.31830350 |
| 24 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.30872222 |
| 25 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.21444167 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.21102091 |
| 27 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.20285437 |
| 28 | Focal adhesion_Homo sapiens_hsa04510 | 1.17554002 |
| 29 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16363746 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12154479 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.04910665 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.00490062 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.99269442 |
| 34 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.94574547 |
| 35 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.94539782 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.91486799 |
| 37 | Tight junction_Homo sapiens_hsa04530 | 0.89195828 |
| 38 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87858419 |
| 39 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.87650440 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87610280 |
| 41 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78632456 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74854906 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73664224 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 0.71373419 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.70210189 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69406052 |
| 47 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66932833 |
| 48 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63464318 |
| 49 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63062973 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.62238706 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62176006 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61992328 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59492434 |
| 54 | Adherens junction_Homo sapiens_hsa04520 | 0.59012454 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58401309 |
| 56 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57519433 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56327421 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55572422 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55302260 |
| 60 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52385173 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51596092 |
| 62 | Salivary secretion_Homo sapiens_hsa04970 | 0.51491672 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.51118296 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.47119640 |
| 65 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46931158 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46435960 |
| 67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44861552 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42047224 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40941273 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.38704478 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38365149 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.37860945 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35473101 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35396987 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34050562 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33894352 |
| 77 | Glioma_Homo sapiens_hsa05214 | 0.31905553 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31574315 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31236475 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30599484 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.29903951 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29345261 |
| 83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.28121702 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.27121517 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24696762 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.24632081 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24624582 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.23542693 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.23009749 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22149703 |
| 91 | Long-term depression_Homo sapiens_hsa04730 | 0.21175701 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18855492 |
| 93 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.17814868 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17746820 |
| 95 | Circadian entrainment_Homo sapiens_hsa04713 | 0.17450668 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.17218113 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.16652479 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16509810 |
| 99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.15756793 |
| 100 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.15235579 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.14107664 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.13434991 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.13335218 |
| 104 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.12466982 |
| 105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.11922749 |
| 106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.11058304 |
| 107 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.10992867 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.10373113 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.10370519 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.10013142 |
| 111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.09505695 |
| 112 | Bile secretion_Homo sapiens_hsa04976 | 0.08128112 |
| 113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.07545234 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.05930731 |
| 115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.05168129 |

